GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (LTS:0RD1) » Definitions » Other Stockholders Equity

Camurus AB (LTS:0RD1) Other Stockholders Equity : kr5 Mil (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Camurus AB Other Stockholders Equity?

Camurus AB's Other Stockholders Equity for the quarter that ended in Dec. 2024 was kr5 Mil.

Camurus AB's quarterly Other Stockholders Equity declined from Jun. 2024 (kr5 Mil) to Sep. 2024 (kr4 Mil) but then increased from Sep. 2024 (kr4 Mil) to Dec. 2024 (kr5 Mil).

Camurus AB's annual Other Stockholders Equity declined from Dec. 2022 (kr4 Mil) to Dec. 2023 (kr2 Mil) but then increased from Dec. 2023 (kr2 Mil) to Dec. 2024 (kr5 Mil).

Camurus AB Other Stockholders Equity Historical Data

The historical data trend for Camurus AB's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camurus AB Other Stockholders Equity Chart

Camurus AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 4.37 2.48 5.20

Camurus AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.48 5.90 5.25 3.91 5.20

Camurus AB Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Camurus AB Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Camurus AB's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Camurus AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (LTS:0RD1) » Definitions » Other Stockholders Equity
Comparable Companies
OSTO:BIOA B OSTO:FLERIE OSTO:BINV OSTO:VICO OSTO:HNSA OSTO:EGTX OSTO:GENO OSTO:XSPRAY OSTO:DMYD B OSTO:SYNACT VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
CAMRF:USA CAMX:Sweden CAMXs:UK 7CA:Germany
Address
Ideon Science Park, Lund, SWE, SE-223 70
Website
https://www.camurus.com
Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The Camurus' clinical pipeline includes products for the treatment of dependence, pain, cancer and endocrine diseases, which are developed in-house and in collaboration with international pharmaceutical companies. The company's product pipeline includes CAM2029, CAM4072 and CAM2043.

Camurus AB Headlines

No Headlines